Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.3 USD | -0.71% | +2.55% | +4.04% |
Apr. 23 | Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating | MT |
Apr. 22 | Scotiabank Adjusts Exelon's Price Target to $37 From $39 | MT |
Financials (USD)
Sales 2024 * | 21.24B | Sales 2025 * | 22B | Capitalization | 37.55B |
---|---|---|---|---|---|
Net income 2024 * | 2.45B | Net income 2025 * | 2.64B | EV / Sales 2024 * | 3.93 x |
Net Debt 2024 * | 46.02B | Net Debt 2025 * | 48.82B | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
15.3
x | P/E ratio 2025 * |
14.3
x | Employees | 19,962 |
Yield 2024 * |
4.11% | Yield 2025 * |
4.36% | Free-Float | 99.67% |
Latest transcript on Exelon Corporation
1 day | -0.27% | ||
1 week | +5.09% | ||
1 month | +2.37% | ||
3 months | +8.12% | ||
6 months | -2.16% | ||
Current year | +4.65% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.58% | 1 M€ | -.--% | - | |
2.45% | 610 M€ | -0.47% | ||
1.56% | 18 M€ | +4.24% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 37.34 | -0.57% | 756 307 |
24-04-23 | 37.56 | -0.29% | 5,700,331 |
24-04-22 | 37.67 | +0.32% | 5,174,426 |
24-04-19 | 37.55 | +2.37% | 6,126,503 |
24-04-18 | 36.68 | +0.71% | 4,395,547 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.65% | 37.55B | |
+8.99% | 136B | |
+4.46% | 80.11B | |
-2.49% | 77.69B | |
+1.21% | 75.76B | |
+61.11% | 59.32B | |
+5.33% | 45.06B | |
+7.81% | 42.44B | |
0.00% | 40.22B | |
-5.93% | 36.24B |
- Stock Market
- Equities
- EXC Stock